Research Centre for Brain and Behaviour
The UCLan Research Centre for Brain and Behaviour brings together biomedical scientists, psychologists, clinicians and chemists to understand how the brain works, including brain disorders, and also to develop novel treatments for Central Nervous System (CNS) disorders.
We specialise in dementia and neurodegeneration, psychiatric illnesses, cognitive neuroscience and neuroscience drug design.
We also work with local charities and colleagues within the UK and internationally on four main strands:
- Dementia and Neurodegeneration: Alzheimer’s disease, neuro-oncology, Motor Neurone disease, Parkinson’s disease, pain, concussion.
- Psychiatric illnesses: depression, anxiety, drug abuse, autism spectrum disorders, attention deficit hyperactivity disorder.
- Cognitive neuroscience: attention, distraction, memory, reasoning, judgment, decision making, problem-solving, intelligence, creativity, vision, language, reading, concussion.
- Neuroscience drug design: computational modelling, in silico studies, medicinal chemistry
Our aim is to promote the University’s inter- and cross-disciplinary research into the brain and behaviour and to form links with similar researchers across the world. We will mentor women and early career researchers and engage with local charities and the community. Ultimately, we hope to produce impactful research through a process of knowledge transfer.
News and events
- Research within the Centre is referenced in a guest blog on the Northern Health Science Alliance website about Alzheimer’s disease, entitled ‘Alzheimer's and the AI Grand Challenge’.
- In January 2020 the Centre hosted Dr Atticus Hainsworth, Reader in Cerebrovascular Disease at St George’s Medical School, London who gave a seminar - “Small vessels in old brains - a pipeline to dementia". He is an expert in the pathology of cerebral small vessel disease, which is the primary cause of lacunar stroke and vascular cognitive impairment. He has authored systematic reviews of animal models relevant to vascular cognitive impairment, and chairs the vascular experimental medicine group within Dementias Platform UK.
- Postdoctoral Research Associate, Dr Maria Paraskevaidi, was the lead investigator of a study into the early detection of endometrial cancer and at-risk patients. This breakthrough, published in ‘Cancers’ journal, is an important step forward for patients, clinicians and the research community. Maria was also interviewed by VJDementia journal (the Video Journal of Dementia) about research into Alzheimer’s disease.